We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 20 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 39 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 09. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 03. 25. | B of A Securities | — | Upgrade | Neutral → Buy | — | B of A Securities: Neutral → Buy |
| 2026. 03. 05. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 02. 27. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 02. 27. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 02. 26. | Citizens | — | Maintain | Market Outperform → Market Outperform | — | Citizens: Market Outperform |
| 2026. 02. 26. | Stifel | — | Maintain | Hold → Hold | — | Stifel: Hold |
| 2026. 02. 24. | Wolfe Research | — | Initiate coverage | — → Outperform | — | Wolfe Research: Outperform |
| 2026. 02. 23. | Mizuho | — | Upgrade | Neutral → Outperform | — | Mizuho: Neutral → Outperform |
| 2026. 02. 07. | Oppenheimer | — | Maintain | Perform → Perform | — | Oppenheimer: Perform |
| 2026. 02. 04. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2026. 02. 03. | Citizens | — | Maintain | Market Outperform → Market Outperform | — | Citizens: Market Outperform |
| 2026. 02. 03. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 01. 07. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 01. 07. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 12. 16. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 12. 11. | Stifel | — | Maintain | Hold → Hold | — | Stifel: Hold |
| 2025. 12. 03. | Mizuho | — | Maintain | Neutral → Neutral | — | Mizuho: Neutral |
| 2025. 11. 18. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 11. 07. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2025. 11. 06. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2025. 10. 21. | Citigroup | — | Initiate coverage | — → Buy | — | Citigroup: Buy |
| 2025. 09. 29. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 09. 24. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2025. 09. 11. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2025. 09. 09. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 08. 09. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 08. 08. | B of A Securities | — | Maintain | Neutral → Neutral | — | B of A Securities: Neutral |
| 2025. 08. 08. | Goldman Sachs | — | Maintain | Sell → Sell | — | Goldman Sachs: Sell |
| 2025. 08. 07. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2025. 08. 07. | Mizuho | — | Maintain | Neutral → Neutral | — | Mizuho: Neutral |
| 2025. 08. 07. | JMP Securities | — | Maintain | Market Outperform → Market Outperform | — | JMP Securities: Market Outperform |
| 2025. 07. 24. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2025. 06. 28. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 06. 27. | Oppenheimer | — | Maintain | Perform → Perform | — | Oppenheimer: Perform |
| 2025. 06. 26. | JMP Securities | — | Maintain | Market Outperform → Market Outperform | — | JMP Securities: Market Outperform |
| 2025. 06. 26. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 06. 26. | Needham | — | Maintain | Buy → Buy | — | Needham: Buy |
| 2025. 06. 24. | RBC Capital | — | Maintain | Outperform → Outperform | — | RBC Capital: Outperform |
| 2025. 06. 07. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |